Home > Pharmacy > Other > Volume-8 > Issue-4 > Ganoderma

Ganoderma

Call for Papers

Volume-8 | Issue-6

Last date : 27-Dec-2024

Best International Journal
Open Access | Peer Reviewed | Best International Journal | Indexing & IF | 24*7 Support | Dedicated Qualified Team | Rapid Publication Process | International Editor, Reviewer Board | Attractive User Interface with Easy Navigation

Journal Type : Open Access

First Update : Within 7 Days after submittion

Submit Paper Online

For Author

Research Area


Ganoderma


Suryawanshi Dipak P | Walzade Om H | Suryawanshi Dipali P



Suryawanshi Dipak P | Walzade Om H | Suryawanshi Dipali P "Ganoderma" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-4, August 2024, pp.1-8, URL: https://www.ijtsrd.com/papers/ijtsrd67111.pdf

Ganoderma lucidum is a versatile mushroom. Polysaccharides and triterpenoids are the main constituents bioactive compounds and have been used as traditional medicinal mushrooms since ancient times. Ganoderma lucidum has a long history of medicinal use in Far Eastern countries for over 2000 years due to its healing properties. Recently, G. lucidum has been scientifically studied to evaluate its content of bioactive components that affect human physiology and has been exploited for effective components in the pharmacology, nutraceuticals. G. Lucidum extracts and its bioactive compounds have been used as an alternative to antioxidants and antimicrobials. agents. Secondary metabolites with many medicinal properties make it a potential substitute could be used as an Anti-Tumor, anticancer, antimicrobial, anti-inflammatory and antidiabetic agent. For example, evidence is accumulating on the potential of this mushroom species as a promising antiviral drug for the treatment of many viral diseases, such as more recently coronavirus disease 2019 (COVID-19). Nevertheless, further research studies on the biotherapeutic components of G. lucidum are necessary to ensure the safety and efficiency of G. lucidum.

Ganoderma lucidum, bioactive compounds, anticancer, Anti-tumor, Antimicrobial, Antiviral, antidiabetic, COVID-19


IJTSRD67111
Volume-8 | Issue-4, August 2024
1-8
IJTSRD | www.ijtsrd.com | E-ISSN 2456-6470
Copyright © 2019 by author(s) and International Journal of Trend in Scientific Research and Development Journal. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (http://creativecommons.org/licenses/by/4.0)

International Journal of Trend in Scientific Research and Development - IJTSRD having online ISSN 2456-6470. IJTSRD is a leading Open Access, Peer-Reviewed International Journal which provides rapid publication of your research articles and aims to promote the theory and practice along with knowledge sharing between researchers, developers, engineers, students, and practitioners working in and around the world in many areas like Sciences, Technology, Innovation, Engineering, Agriculture, Management and many more and it is recommended by all Universities, review articles and short communications in all subjects. IJTSRD running an International Journal who are proving quality publication of peer reviewed and refereed international journals from diverse fields that emphasizes new research, development and their applications. IJTSRD provides an online access to exchange your research work, technical notes & surveying results among professionals throughout the world in e-journals. IJTSRD is a fastest growing and dynamic professional organization. The aim of this organization is to provide access not only to world class research resources, but through its professionals aim to bring in a significant transformation in the real of open access journals and online publishing.

Thomson Reuters
Google Scholer
Academia.edu

ResearchBib
Scribd.com
archive

PdfSR
issuu
Slideshare

WorldJournalAlerts
Twitter
Linkedin